Kibum Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Author Correction: O-GlcNAc modification of leucyl-tRNA synthetase 1 integrates leucine and glucose availability to regulate mTORC1 and the metabolic fate of leucine.
Journal: Nature communications
Published: October 21, 2022
Enhanced Glutaminolysis Drives Hypoxia-Induced Chemoresistance in Pancreatic Cancer.
Journal: Cancer research
Published: June 23, 2022
O-GlcNAc modification of leucyl-tRNA synthetase 1 integrates leucine and glucose availability to regulate mTORC1 and the metabolic fate of leucine.
Journal: Nature communications
Published: December 16, 2021
Structure-based modification of pyrazolone derivatives to inhibit mTORC1 by targeting the leucyl-tRNA synthetase-RagD interaction.
Journal: Bioorganic chemistry
Published: December 17, 2020
Leucine-sensing mechanism of leucyl-tRNA synthetase 1 for mTORC1 activation.
Journal: Cell reports
Published: July 05, 2020
Therapeutic effects of the novel Leucyl-tRNA synthetase inhibitor BC-LI-0186 in non-small cell lung cancer.
Journal: Therapeutic advances in medical oncology
Published: October 13, 2018
Glucose-dependent control of leucine metabolism by leucyl-tRNA synthetase 1.
Journal: Science (New York, N.Y.)
Published: May 24, 2018
Control of leucine-dependent mTORC1 pathway through chemical intervention of leucyl-tRNA synthetase and RagD interaction.
Journal: Nature communications
Published: November 02, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026